These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32904627)

  • 1. The Contradictory Role of Interleukin-33 in Immune Cells and Tumor Immunity.
    Zhang X; Chen W; Zeng P; Xu J; Diao H
    Cancer Manag Res; 2020; 12():7527-7537. PubMed ID: 32904627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.
    Choi MR; Sosman JA; Zhang B
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.
    Fournié JJ; Poupot M
    Front Immunol; 2018; 9():2506. PubMed ID: 30416507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.
    Lu B; Yang M; Wang Q
    J Mol Med (Berl); 2016 May; 94(5):535-43. PubMed ID: 26922618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.
    Coyle AJ; Lloyd C; Tian J; Nguyen T; Erikkson C; Wang L; Ottoson P; Persson P; Delaney T; Lehar S; Lin S; Poisson L; Meisel C; Kamradt T; Bjerke T; Levinson D; Gutierrez-Ramos JC
    J Exp Med; 1999 Oct; 190(7):895-902. PubMed ID: 10510079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-33 and the intestine: The good, the bad, and the inflammatory.
    Hodzic Z; Schill EM; Bolock AM; Good M
    Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-18: a regulator of cancer and autoimmune diseases.
    Esmailbeig M; Ghaderi A
    Eur Cytokine Netw; 2017 Nov; 28(4):127-140. PubMed ID: 29478963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of IL-33/ST2 Pathway in Tumorigenesis.
    Larsen KM; Minaya MK; Vaish V; Peña MMO
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
    O'Sullivan ST; Lederer JA; Horgan AF; Chin DH; Mannick JA; Rodrick ML
    Ann Surg; 1995 Oct; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive production of Th2 cytokines by human CD4+ effector T cells transiently expressing the natural killer cell marker CD57/HNK1.
    Brinkmann V; Kristofic C
    Immunology; 1997 Aug; 91(4):541-7. PubMed ID: 9378492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of interleukin-10 levels in malignant pleural effusion.
    Chen YM; Yang WK; Whang-Peng J; Kuo BI; Perng RP
    Chest; 1996 Aug; 110(2):433-6. PubMed ID: 8697847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
    Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE
    Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal surgical interventions: local and systemic consequences for the immune system--a prospective study on elective gastrointestinal surgery.
    Decker D; Tolba R; Springer W; Lauschke H; Hirner A; von Ruecker A
    J Surg Res; 2005 Jun; 126(1):12-8. PubMed ID: 15916969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles.
    Seo N; Tokura Y
    J Interferon Cytokine Res; 1999 Jun; 19(6):555-61. PubMed ID: 10433355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
    Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
    Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
    Kitajima M; Ito T; Tumes DJ; Endo Y; Onodera A; Hashimoto K; Motohashi S; Yamashita M; Nishimura T; Ziegler SF; Nakayama T
    Cancer Res; 2011 Jul; 71(14):4790-8. PubMed ID: 21646476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-27 in T cell immunity.
    Iwasaki Y; Fujio K; Okamura T; Yamamoto K
    Int J Mol Sci; 2015 Jan; 16(2):2851-63. PubMed ID: 25633106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.